Zhao Xiang Bian
Direttore/Membro del Consiglio presso The School of Chinese Medicine of The University of Hong Kong
Posizioni attive di Zhao Xiang Bian
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Hong Kong Baptist University | Corporate Officer/Principal | - | - |
| The School of Chinese Medicine of The University of Hong Kong | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Zhao Xiang Bian
Precedenti posizioni note di Zhao Xiang Bian
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| DAFENG PORT HESHUN TECHNOLOGY COMPANY LIMITED | Direttore/Membro del Consiglio | 15/05/2015 | 28/03/2024 |
| Independent Dir/Board Member | 15/05/2015 | 28/03/2024 | |
| ZHEJIANG TENGY ENVIRONMENTAL TECHNOLOGY CO., LTD | Segretario Aziendale | - | 31/01/2018 |
| SHANDONG LUOXIN PHARMACY GROUP CO LTD | Comptroller/Controller/Auditor | - | 31/12/2017 |
| Segretario Aziendale | - | 31/12/2017 |
Formazione di Zhao Xiang Bian
| Nanjing University of Chinese Medicine | Undergraduate Degree |
| Guangzhou University of Chinese Medicine | Undergraduate Degree |
| Beijing University of Traditional Chinese Medicine | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Cina | 6 |
| Hong Kong | 4 |
Posizioni
| Undergraduate Degree | 3 |
| Director/Board Member | 2 |
| Corporate Secretary | 2 |
Settori
| Consumer Services | 6 |
| Distribution Services | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| DAFENG PORT HESHUN TECHNOLOGY COMPANY LIMITED | Distribution Services |
| ZHEJIANG TENGY ENVIRONMENTAL TECHNOLOGY CO., LTD | Producer Manufacturing |
| Aziende private | 1 |
|---|---|
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
 Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. engages in the manufacture, sale, research and development of pharmaceutical products. Its products include anti-infective, antiviral, respiratory system, digestive system, nervous, endocrine, cardiovascular system, antipyretic, analgesics & anti-inflammatory, oncology, anti-allergic APIs & intermediates, lyophilized powder for injection preparation, solid preparation, chemical raw medicine, cephalosporin raw medicine and oral cephalosporin series. The company was founded on May 05, 1998 and is headquartered in Linyi, China. | Health Technology |
- Borsa valori
- Insiders
- Zhao Xiang Bian
- Esperienza
